Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and…
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024. The agreement is effective fromJanuary 1, 2024and commercialisation commenced onFebruary 1, 2024. Matt Erick, Chief Commercial Officer of Advanced Markets, Biocon Biologics Ltd, said:"Following the recent establishment of our strategic partnership with Sandoz inJapan, our agreement with Sandoz inAustraliamarks another important milestone of our global partnership and...
PR Newswire
09/02/2024
Medscape Education Leads the Industry into New Era of Precision Education with…
"It's increasingly crucial to demonstrate both patient impact and value. At Medscape Education, we've eagerly embraced this challenge. As the pioneering force in continuing medical education, boasting over 29 years of experience in curating trusted content for our expansive membership of healthcare professionals around the world, we are redefining the possibilities in medical education," shared Christina Hoffman, MS, Chief Strategy Officer of Medscape Education. "It's increasingly…
PR Newswire
08/02/2024
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15…
About Alkermes plcAlkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham…
PR Newswire
08/02/2024
Groupe Casino: Group Casino announces that it has reached agreements with…
Group Casino announces that it has reached agreements with Carrefour for the sale of 25 Casino hypermarkets and supermarkets Paris, 8 February 2024Pursuant to the memorandum of understanding entered into with Groupement Les Mousquetaires on 24 January 2024 1, Groupement Les Mousquetaires has substituted Carrefour for the acquisition of some stores that were initially supposed to be acquired by Groupement Les Mousquetaires. In this context, Casino and Carrefour have entered into...
Nasdaq GlobeNewswire
08/02/2024
The IV Catheters Market to Reach $6.6 Billion by 2029 - Exclusive Focus Insight…
To Know More, Download the Free Sample Report:https://www.focusreports.store/request-sample/global-iv-catheters-market-focused-insights To Know More, Download the Free Sample Report: https://www.focusreports.store/request-sample/global-iv-catheters-market-focused-insights IV Catheters Market Report Scope In 2023, the global intravenous catheters market was dominated byNorth America, with a share of 33.45%. This region has a large presence of major vendors offering various IVCs...
PR Newswire
08/02/2024
The Novozymes Report 2023
This annual report has been released subsequent to the approval of the combination of Novozymes and Chr. Hansen on January 29, 2024. The new combined group is called Novonesis. As an annual report is required to cover the activities of a group during a financial year, this report only discloses Novozymes' financial and non-financial performance in 2023. Non-financial elements concerning the combined group, Novonesis, are provided in separate and clearly labeled sections. Read more about...
Nasdaq GlobeNewswire
08/02/2024
IAG names Roughan Sheedy CEO
Roughan Sheedy, previously COO at Invicro, brings over 20 years of success in leading and scaling high-performance imaging clinical research and technology companies. Roughan has held senior roles in Finance and Commercial and has a depth of experience of driving global growth and expansion throughout Europe, the US and Asia. Roughan Sheedy, previously COO at Invicro, brings over 20 years of success in leading and scaling high-performance imaging clinical research and technology companies...
PR Newswire
08/02/2024
Multi-Billion Opportunities in the US Clinical Laboratory Tests Market, More…
Browse In-Depth TOC on the US Clinical Laboratory Tests Market Browse In-Depth TOC on the US Clinical Laboratory Tests Market 186 – Pages 34 - Tables 78 - Figures U.S. Clinical Laboratory Tests Market Report Scope • High Demand for Early & Preventive Diagnosis Telemedicine and Direct-to-Consumer Solutions Creating New Market Opportunities The COVID-19 pandemic has spurred significant transformations in the operations of clinical...
PR Newswire
08/02/2024
The Door and Window Handles Market to Boom, the Market to Hit $17.70 Billion by…
Browse In-depth TOC on the Door and Window Handles Market Browse In-depth TOC on the Door and Window Handles Market 356 – Pages 202 - Tables 95 - Figures Door and Window Handles Market Report Scope • Revival of the Travel & Tourism Industry • Growing Demand in Emerging Countries Rapid urbanization has opened up better job opportunities for people, which has led to an improvement in living standards and an increase in per...
PR Newswire
08/02/2024
Russia Medical Consumables Market Booms to $118.7M by 2027, Driven by Healthcare…
Interested to Know More about this Report, Request a Free Sample Report Interested to Know More about this Report, Request a Free Sample Report Fueling the Growth: Market Segmentation: Visit this Link :- Request for custom report Competitive Landscape: Looking Ahead: The future of theRussiamedical consumables market appears bright. Continued healthcare investments, technological advancements, and an aging population are expected to propel...
PR Newswire
08/02/2024
Cryogenic Pump Market Size to Grow USD 854.0 Million by 2030 at a CAGR of 3.4% |…
Claim Your Free Sample Now: https://reports.valuates.com/request/sample/ALLI-Auto-1J239/_Cryogenic_Pump_Market Claim Your Free Sample Now:https://reports.valuates.com/request/sample/ALLI-Auto-1J239/_Cryogenic_Pump_Market Major Factors Driving the Growth of Cryogenic Pump Market High flow rates, dependability, and a low chance of thermal losses make kinetic pumps the ideal option for transporting liquefied gasses in cryogenic settings. The market for cryogenic pumps is...
PR Newswire
08/02/2024
Animal Wound Care Market Worth $2.0 Billion | MarketsandMarkets™.
Browse in-depth TOC on "Animal Wound Care Market" Browse in-depth TOC on "Animal Wound Care Market" Animal Wound Care Market Scope: The expansion of the market is not limited to companion animals; it extends to livestock as well. Livestock owners are increasingly recognizing the economic importance of proper wound care in enhancing productivity, while wildlife conservation efforts rely on these products to treat injuries in endangered species. Opportunities abound in the…
PR Newswire
08/02/2024
Major Depressive Disorder - Market Outlook, Epidemiology, Competitive Landscape…
Not only psychiatrists, but primary care practitioners are also involved in the routine management of MDD patients in most of the major markets. Thelansis's primary market research highlights some differences in the treatment practices between these physician specialties for MDD patients, with psychiatrists managing more severe MDD patients and MDD patients with other comorbidities (e.g., post-traumatic stress disorder PTSD). In the MDD report content, Thelansis covers various classes of drugs…
PR Newswire
08/02/2024
Össur climate targets validated by the Science Based Targets initiative
In its ambition to become net-zero by 2050, Össur also commits to reducing absolute Scope 1 and 2 greenhouse gas emissions by 90% by 2050 from a 2019 base year and to reduce absolute Scope 3 emissions by 90% by 2050 from a 2021 base year. In its ambition to become net-zero by 2050, Össur also commits to reducing absolute Scope 1 and 2 greenhouse gas emissions by 90% by 2050 from a 2019 base year and to reduce absolute Scope 3 emissions by 90% by 2050 from a 2021 base year. These ambitious...
PR Newswire
08/02/2024
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 8 February 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
08/02/2024
DONNA KARAN NEW YORK UNVEILS MAJOR RELAUNCH WITH "IN WOMEN WE TRUST" CAMPAIGN…
8 ICONSEight extraordinary women, each an icon in her own right—Cindy Crawford, Linda Evangelista, Amber Valletta, Shalom Harlow, Carolyn Murphy, Imaan Hammam, Karlie Kloss, and Liya Kebede—all come together for the first time to share inspiring tributes of Donna Karan's influence. Each with their own personal connection to the brand over different eras, they epitomize the brand's relentless celebration of empowered women. "Donna represents strength and sensuality. You can be whoever you…
PR Newswire
08/02/2024
Accumulus Synergy Launches Highly Anticipated Cloud-Based Platform
Regulatory Authorities Around the World Engage as the Nonprofit Supports a Global Reliance Project “Today marks the beginning of a new era for the life sciences - regulatory ecosystem,” commented Frank Nogueira, Accumulus Chief Executive Officer. “This release is the first step toward achieving our mission to dramatically accelerate critical therapies to citizens of the world. We believe that there has never been a better time to use advanced technologies to simplify regulatory...
Nasdaq GlobeNewswire
08/02/2024
The Eye in AI: Revolutionizing Eye Exams
This time is different though. You learn that your eye exam can be done downstairs, in the cafeteria where you work, and there is no need to drive anywhere. Right after lunch, you go there, sit down, and look through a compact device placed in front of you. No special room, no chart on the wall, and your eye care professional is interacting with you remotely, through a tablet that controls the device. To your surprise, as you look through the binocular-like instrument, you no longer have to play…
PR Newswire
08/02/2024
Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024
On Medlab 2024, Tianlong announces its brand-new product - Gentier X3 Series Real-time PCR System, which innovates in flexibility and allows users to control three independent blocks in the same PCR system, gained popularity on the exhibition. With Gentier X3, maximum 3×32-well samples can be run in three different protocols on three independent thermal blocks simultaneously. With the powerful and efficient temperature control system, user-friendly operational designs, it can provide maximal…
PR Newswire
08/02/2024
Sai Life Sciences releases its Sustainability Report 2023
Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released itsSustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme 'Steadfast on Sustainability,' and it articulates the company's commitment to sustainability and the journey so far. Read the full reporthere. Making this announcement, Krishna Kanumuri, CEO...
Nasdaq GlobeNewswire
08/02/2024
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of…
Dr. Cesano succeeds Dr. Kenneth Hillan, who will step down effective today after a successful 7-year tenure as a director of Zymeworks.“Zymeworks is honored to welcome Dr. Cesano to our board of directors,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. “She brings more than 25 years of experience in drug development, diagnostics, and cancer immunology. Her appointment further refreshes and strengthens the governance structure of the company, and her guidance will...
Nasdaq GlobeNewswire
08/02/2024
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to…
Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both companies' autologous CAR-T programs towards market, pending market authorization BioNTech secures the right to utilize Autolus' manufacturing capacity in a cost-efficient set-up to accelerate the development of BNT211 into pivotal trials in CLDN6+ tumors BioNTech to support launch and expansion of development program of Autolus' lead cell therapy candidate...
Nasdaq GlobeNewswire
08/02/2024
Persistent Launches Population Health Management Solution Using Microsoft Azure…
In addition, Persistent's PHM Solution assists a physician or a caregiver in recommending personalized interventions through community-based programs and care management teams to prevent emergency department visits, avoidable readmissions, and extended hospital stays. The Solution decreases 30-day readmissions by up to 60%, and continuously monitors correlations and outcomes to ensure quality patient engagement. In addition, Persistent's PHM Solution assists a physician or a caregiver in...
PR Newswire
08/02/2024
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
Full Year 2023 Full Year 2023 Outlook 2024 "Sobi's strategic portfolio grew strongly during the quarter and accounted for 40 per cent of revenue, underpinning our commitment to deliver new innovative medicines to people with rare diseases." - Guido Oelkers, President & CEO. Investors, analysts, and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the same day at ...
PR Newswire
08/02/2024
Altri Comunicati